Skip to main content
SpringerLink
Log in
Book cover

Purine Metabolism in Man-III pp 283–286Cite as

Benzbromarone as a Long-Term Uricosuric Agent

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 122A))

Abstract

Benzbromarone is a potent uricosuric drug with a rapid onset and relatively long duration of action. It belongs to a new class of antihyperuricemic compounds and has the following structural formula and name:

3- (3,5-dibromo-4-hydroxybenzoyl) — 2 — ethylbenzofuran

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Zollner N, Dofel W, Grobner W: The effect of benzbromarone on urinary uric acid excretion in normal adults. Klin Wochensehr 48, 426–432, 1970

    Article  CAS  Google Scholar 

  2. Mertz DP, Sulzberger I, Klopfer M: Diabetes mellitus, hyperlipidemia, fatty liver, hypertension with primary gout and the effect of benzbromarone. Munch Med Wochenschr 112, 241–247, 1970

    PubMed  CAS  Google Scholar 

  3. Kotzaurek R, Hueber EF: Clinical experience with 2-ethyl-3 (4-hydroxy-3,5-dibrombenzol-benzofuran (benzbromarone) in the treatment of gout and hyperuricemia. Wien Klin Wochenschr 118, 1014–1018 (No 23), 1968

    CAS  Google Scholar 

  4. VanBogaert P: Clinical trial of L2214 in the treatment of gout or rheumatological syndromes associated with hyperuricemia. Belg Rheum Med Phys 24, 295–315, 1969

    Google Scholar 

  5. Masbernard A, Guilbaud J, Droniou J: Clinical experience in long-term treatment of primary gout with benzofuranne iodine and brome-derivatives. Soc Med Chir Hop 3, 393–410, 1971

    Google Scholar 

  6. Broekhuysen J. Pacco M, Sion R, Demeulenaere L, Van Hee M: Metabolism of benzbromarone in man. Eur J Clin Pharmacol 4/2, 125–130, 1972

    Article  PubMed  CAS  Google Scholar 

  7. Oshima Y, Yoshimura T, Akaoka U, Mishida S: Clinical experience with benzbromarone in gout. Ryumachi 9/1, 49, 1969

    Google Scholar 

  8. Bresnik W, Muller MM: Results obtained with long-term benzbromarone therapy. Wien Klin Wochenschr 86/10, 283–287, 1974.

    PubMed  CAS  Google Scholar 

  9. Delbarre F, Auscher C, Saporta L, De Gery A, Danchot J: Treatment of gout with a dibrominated derivative of benzofuran. Rev Rheum Mal Osteo-Artic 40/4, 273–275, 1973

    Google Scholar 

  10. Sorensen LB, Levinson DJ: Clinical evaluation of benzbromarone. A new uricosuric drug. Arthritis Rheum 19/2, 183–190, 1976

    Article  PubMed  CAS  Google Scholar 

  11. Sinclair DS, Fox IH: The pharmacology of hypouricemic effect of benzbromarone. J Rheum 2/4, 437–445, 1975

    PubMed  CAS  Google Scholar 

  12. Yu Ta-F: Pharmacokinetic and clinical studies of a new uricosuric agent — benzbromarone. J Rheum 3/3, 305–312, 1976.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology Section, Wadsworth VA Hospital, USA

    Rodney Bluestone M.B., M.R.C.P. (Chief, Professor of Medicine, Chairman, Professor of Medicine, Director of Clinical Research & International Coordinator), James Klinenberg M.D. (Chief, Professor of Medicine, Chairman, Professor of Medicine, Director of Clinical Research & International Coordinator) & Ian K. Lee M.B., Ch.B. (Chief, Professor of Medicine, Chairman, Professor of Medicine, Director of Clinical Research & International Coordinator)

  2. UCLA Medical Center, USA

    Rodney Bluestone M.B., M.R.C.P. (Chief, Professor of Medicine, Chairman, Professor of Medicine, Director of Clinical Research & International Coordinator), James Klinenberg M.D. (Chief, Professor of Medicine, Chairman, Professor of Medicine, Director of Clinical Research & International Coordinator) & Ian K. Lee M.B., Ch.B. (Chief, Professor of Medicine, Chairman, Professor of Medicine, Director of Clinical Research & International Coordinator)

  3. Department of Medicine, Cedars-Sinai Medical Center, USA

    Rodney Bluestone M.B., M.R.C.P. (Chief, Professor of Medicine, Chairman, Professor of Medicine, Director of Clinical Research & International Coordinator), James Klinenberg M.D. (Chief, Professor of Medicine, Chairman, Professor of Medicine, Director of Clinical Research & International Coordinator) & Ian K. Lee M.B., Ch.B. (Chief, Professor of Medicine, Chairman, Professor of Medicine, Director of Clinical Research & International Coordinator)

  4. Mead Johnson Pharmaceutical Division, USA

    Rodney Bluestone M.B., M.R.C.P. (Chief, Professor of Medicine, Chairman, Professor of Medicine, Director of Clinical Research & International Coordinator), James Klinenberg M.D. (Chief, Professor of Medicine, Chairman, Professor of Medicine, Director of Clinical Research & International Coordinator) & Ian K. Lee M.B., Ch.B. (Chief, Professor of Medicine, Chairman, Professor of Medicine, Director of Clinical Research & International Coordinator)

Authors
  1. Rodney Bluestone M.B., M.R.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Klinenberg M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ian K. Lee M.B., Ch.B.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Fundación Jiménez Díaz, Madrid, Spain

    Aurelio Rapado

  2. M.R.C. Clinical Research Centre, Harrow, England

    R. W. E. Watts

  3. Department of Human Genetics, University of Nijmegen Faculty of Medicine, Nijmegen, The Netherlands

    Chris H. M. M. De Bruyn

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Plenum Press, New York

About this chapter

Cite this chapter

Bluestone, R., Klinenberg, J., Lee, I.K. (1980). Benzbromarone as a Long-Term Uricosuric Agent. In: Rapado, A., Watts, R.W.E., De Bruyn, C.H.M.M. (eds) Purine Metabolism in Man-III. Advances in Experimental Medicine and Biology, vol 122A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9140-5_46

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-9140-5_46

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-9142-9

  • Online ISBN: 978-1-4615-9140-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation